The animals were euthanized 0, 7 and 28 days after bleomycin challenge. Treatment with hfPMSCs showed that these cells can attenuate bleomycin-induced lung inflammation and fibrosis in mice, in part through a mechanism by attenuating MyD88-mediated inflammation. The gene discussed is MYD88; the disease is inflammation.